Novel allosteric mechanism of p53 activation by small molecules for targeted anticancer therapy
Joanna Zawacka-Pankau, Vera V. Grinkevich, Mikhail Burmakin, Aparna Vema, Karin Fawkner, Natalia Issaeva, Virginia Andreotti, Eleanor R. Dickinson, Elisabeth Hedström, Clemens Spinnler, Alberto Inga, Lars-Gunnar Larsson, Anders Karlén, Olga Tarasova, Vladimir Poroikov, , Galina Selivanova
This study identifies a novel allosteric mechanism by which small molecules activate p53 by blocking MDM2/MDMX binding, offering a new approach for anticancer therapy.
bioRxiv · Dec 7, 2018 · PreprintCancer Biology